Roland Andersson, Board member since 2019.
Born 1955. Professor of surgery, Lunds University.
Professor of surgery at Lund University since 2000. Solid clinical experience and clinical and transitional research. Author of more than 500 articles in peer-reviewed journals. Supervisor for about 30 completed graduate students in the areas of cancer, systematic inflammation, organ failure and bowel function.
Other ongoing assignments: Professor of surgery, Lund University. CEO and board member of Foresight Pharma AB. Chairman of the Board of Reccan Diagnostics AB. Board member at Nordic Biotechnology AB, Aqilion AB and Nordic Oncology in Lund AB.
Number of shares: 100,000
Number of TO4: 95,000
Independent of company, independent of larger shareholders.